AZ's Baselga on tailored treatments and the march to cure cancer by Amirah Al Idrus Tuesday, June 4, 2019 José Baselga, AstraZeneca's R&D chief, discussed capivasertib, how to pick the best drug for patients and what needs to change before cancer is cured.
